Aurinia Pharmaceuticals
IPOChanging the Trajectory of Autoimmune Diseases
- Employees
- 51–200
- Business Model
- B2B
- Website
- auriniapharma.com
- Type
- Public
About
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on treating autoimmune diseases with high unmet medical needs. Its lead commercial product, LUPKYNIS (voclosporin), is approved for lupus nephritis. The company is advancing a pipeline including aritinercept for additional autoimmune indications.
Summary
Aurinia Pharmaceuticals is a Biotech company.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2001
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aurinia-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/aurinia-pharmaceuticals" alt="Aurinia Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>